Financials in USD. Standardized financial statements.
A compact view of how ACADIA Pharmaceuticals Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.07B | $957.80M | $726.44M | $517.24M | $484.14M | $441.75M | $339.08M | $223.81M | $124.90M | $17.33M |
| Revenue Growth? | +11.9% | +31.8% | +40.4% | +6.8% | +9.6% | +30.3% | +51.5% | +79.2% | +620.7% | 0.0% |
| Cost of Revenue? | $89.00M | $81.84M | $45.73M | $10.17M | $19.14M | $20.55M | $19.60M | $18.33M | $13.06M | $4.41M |
| Gross Profit? | $982.51M | $875.96M | $680.71M | $507.07M | $465.00M | $421.20M | $319.48M | $205.48M | $111.84M | $12.93M |
| Gross Margin? | +91.7% | +91.5% | +93.7% | +98.0% | +96.0% | +95.3% | +94.2% | +91.8% | +89.5% | +74.6% |
| Operating Expenses? | $877.70M | $645.16M | $754.09M | $730.66M | $635.44M | $707.79M | $566.02M | $452.92M | $404.25M | $285.74M |
| Operating Income? | $104.81M | $230.79M | -$73.38M | -$223.60M | -$170.44M | -$286.59M | -$246.54M | -$247.44M | -$292.41M | -$272.81M |
| EBITDA? | $138.90M | $100.16M | -$67.83M | -$221.57M | -$167.09M | -$283.65M | -$243.78M | -$244.44M | -$289.70M | -$270.99M |
| Income Before Tax | $138.90M | $258.07M | -$51.04M | -$213.44M | -$167.52M | -$280.97M | -$234.38M | -$243.94M | -$288.28M | -$270.05M |
| Income Tax Expense | -$252.10M | $31.62M | $10.25M | $2.53M | $351,000 | $611,000 | $876,000 | $1.26M | $1.12M | $1.34M |
| Net Income? | $391.00M | $226.45M | -$61.29M | -$215.97M | -$167.87M | -$281.58M | -$235.26M | -$245.19M | -$289.40M | -$271.39M |
| EPS? | $2.32 | $1.37 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | $-1.60 | $-1.94 | $-2.36 | $-2.34 |
| Diluted EPS? | $2.29 | $1.36 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | $-1.60 | $-1.94 | $-2.36 | $-2.34 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality